Delivery Order SPE2DB25D2207-SPE2DB25FQRST
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens in 0.5 mL quantities, with a ceiling value of $8,408.08. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,108.65 on September 9, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a $80,070.90 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This firm fixed price, non-set-aside contract was competitively awarded and is scheduled for completion by September 3, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within...
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency awarded a $26.7K delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 10 mg/0.5 mL pens with an ultimate completion date of September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's significant role as a pharmaceutical supplier to the federal government, leveraging...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,202.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $27,721.55 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 29, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 2, 2025, and involves performance at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a discrete fulfillment under AmerisourceBergen's larger pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $13,493.92 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. The contract is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made on a non-set-aside basis through competitive procurement, reflecting AmerisourceBergen's established capability to fulfill federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zepbound 5 mg/0.5 mL pens with a contract ceiling value of $3,730.31. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,267.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on September 3, 2025, with completion by September 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB25FQRSTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens with a ceiling value of $6,425.62. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a direct procurement under AmerisourceBergen's broader relationship with the federal government as a critical pharmaceutical distributor supporting military and defense healthcare needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a comprehensive $999.9 billion prime vendor agreement running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical and healthcare solutions provider, AmerisourceBergen maintains an extensive portfolio of federal contracts covering diverse therapeutic areas and medical commodities. The company's status as a non-set-aside awardee demonstrates its competitive capability to fulfill federal procurement requirements without preferential program designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 9/10/25 |